© 2022 MJH Life Sciences and Ophthalmology Times. All rights reserved.
© 2022 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
October 29, 2021
Ongoing nationwide study looks at in vitro antibiotic resistance among isolates.
October 28, 2021
Sustained-release option is deposited directly into the lenticular capsule.
October 27, 2021
Patients can get real-time disease monitoring with self-operated device.
October 26, 2021
Improvements are seen after gene therapy for Leber congenital amaurosis.
October 25, 2021
Investigators have found that the early and late stages of uveal melanoma differ markedly.
October 22, 2021
Three cases demonstrate value of new tools, technology for surgeons.
October 21, 2021
According to investigators, aqueous humor analysis differentiated the tumors in patients.
October 20, 2021
There are times when physicians should be critical of scans.
October 04, 2021
Sustained-release option helps with patient adherence following surgery.
September 30, 2021
Nasotemporal sagittal height asymmetry a good biomarker of shortsightednes.
September 20, 2021
Lens an option for complicated eyes, astigmatism, monovision candidates.
July 26, 2021
Eric Donnenfeld, MD, presents results of the year-long Grail Study demonstrating the safety and performance of the Juvene IOL from LensGen Inc.
Stealth BioTherapeutics announces data from Phase 2 study of geographic atrophy candidate
Ocuphire announces positive topline results from LYNX-1 Phase 3 trial
Kala reaches deal to sell Eysuvis, Inveltys to Alcon